tradingkey.logo
tradingkey.logo
Search

PharmaCyte Biotech Inc

PMCB
Add to Watchlist
0.584USD
-0.016-2.67%
Close 07-31 16:00ETQuotes delayed by 15 min
6.27MMarket Cap
LossP/E TTM

PMCB Income Statement

You can find the annual or quarterly income statement of PharmaCyte Biotech Inc here for insights into the performance and operational efficiency of PharmaCyte Biotech Inc.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q4
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
FY2019Q4
FY2019Q3
FY2019Q2
FY2019Q1
FY2018Q4
FY2018Q3
FY2018Q2
FY2018Q1
FY2017Q4
FY2017Q3
FY2017Q2
FY2017Q1
FY2016Q4
FY2016Q3
FY2016Q2
FY2016Q1
FY2015Q4
FY2015Q3
FY2015Q2
FY2015Q1
FY2014Q4
FY2014Q3
FY2014Q2
FY2014Q1
FY2013Q4
FY2013Q3
FY2013Q2
FY2013Q1
FY2012Q3
FY2012Q2
FY2012Q1
Total revenue
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
----
--0.00
--0.00
--0.00
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
-100.00%0.00
--0.00
-100.00%0.00
-68.32%6.29K
-66.47%6.63K
--20.27K
--19.84K
--19.76K
Revenue
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
----
--0.00
--0.00
--0.00
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
-100.00%0.00
--0.00
-100.00%0.00
-68.32%6.29K
-66.47%6.63K
--20.27K
--19.84K
--19.76K
Cost of revenue
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
--0.00
-100.00%0.00
59.38%9.62K
-100.00%0.00
--2.21K
--6.04K
--15.68K
Operating expenses
-7.68%961.83K
120.58%2.12M
24.41%1.38M
-33.15%848.30K
-10.66%1.04M
-48.62%960.25K
-21.53%1.11M
-38.86%1.27M
29.11%1.17M
20.35%1.87M
-39.21%1.41M
23.49%2.08M
-40.09%903.28K
81.40%1.55M
130.74%2.32M
64.23%1.68M
45.68%1.51M
13.12%856.12K
5.83%1.00M
16.07%1.02M
38.01%1.03M
-13.53%756.85K
-11.02%949.51K
-22.26%881.68K
-36.04%749.89K
29.42%875.31K
2.95%1.07M
-6.69%1.13M
-19.04%1.17M
-66.69%676.35K
-42.87%1.04M
-28.02%1.22M
25.42%1.45M
58.40%2.03M
86.24%1.81M
63.70%1.69M
2.09%1.15M
-28.47%1.28M
-40.45%974.20K
-31.89%1.03M
-71.56%1.13M
23.04%1.79M
-73.81%1.64M
-4.35%1.51M
-75.83%3.98M
113.86%1.46M
1292.30%6.25M
13.03%1.58M
3513.64%16.45M
99.82%681.08K
26.33%448.57K
156.81%1.40M
--455.19K
-20.78%340.84K
-16.17%355.08K
-18.88%545.41K
--430.25K
--423.57K
--672.36K
R&D expenses
-51.12%61.95K
-21.22%93.11K
44.75%141.09K
-0.89%95.16K
34.56%126.73K
-6.74%118.20K
18.82%97.47K
-8.10%96.02K
9.68%94.18K
179.19%126.73K
-53.91%82.03K
-34.40%104.48K
-66.20%85.87K
-71.28%45.39K
31.63%178.00K
10.90%159.27K
-20.67%254.06K
-9.22%158.04K
-10.64%135.22K
-46.92%143.61K
227.96%320.27K
53.66%174.09K
743.44%151.31K
274.08%270.57K
442.14%97.66K
91.56%113.30K
-84.41%17.94K
-72.99%72.33K
-92.86%18.01K
-92.63%59.14K
-77.67%115.10K
-37.38%267.79K
45.09%252.12K
38.44%802.56K
103.12%515.46K
144.38%427.67K
-26.86%173.76K
1.00%579.72K
-42.29%253.77K
12.41%175.00K
-91.68%237.57K
109.63%573.98K
26.44%439.71K
--155.68K
782.64%2.86M
--273.80K
--347.76K
----
--323.50K
--0.00
----
----
----
----
----
----
----
----
----
Depreciation, depletion, and amortization
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
----
----
----
--0.00
--0.00
--0.00
--0.00
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
--8.28K
--7.86K
--8.52K
Other operating expenses
----
----
----
----
---2.53M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Operating profit
7.68%-961.83K
-120.58%-2.12M
-24.41%-1.38M
33.15%-848.30K
10.66%-1.04M
48.62%-960.25K
21.53%-1.11M
38.86%-1.27M
-29.11%-1.17M
-20.35%-1.87M
39.21%-1.41M
-23.49%-2.08M
40.09%-903.28K
-81.40%-1.55M
-130.74%-2.32M
-64.23%-1.68M
-45.68%-1.51M
-13.12%-856.12K
-5.83%-1.00M
-16.07%-1.02M
-38.01%-1.03M
13.53%-756.85K
11.02%-949.51K
22.26%-881.68K
36.04%-749.89K
-29.42%-875.31K
-2.95%-1.07M
6.69%-1.13M
19.04%-1.17M
66.69%-676.35K
42.87%-1.04M
28.02%-1.22M
-25.42%-1.45M
-58.40%-2.03M
-86.24%-1.81M
-63.70%-1.69M
-2.09%-1.15M
28.47%-1.28M
40.45%-974.20K
31.89%-1.03M
71.56%-1.13M
-23.04%-1.79M
73.81%-1.64M
4.35%-1.51M
75.83%-3.98M
-113.86%-1.46M
-1292.30%-6.25M
-13.03%-1.58M
-3513.64%-16.45M
-99.82%-681.08K
-28.61%-448.57K
-159.97%-1.40M
---455.19K
16.86%-340.84K
13.61%-348.80K
17.44%-538.79K
---409.98K
---403.73K
---652.60K
Net non-operating interest income (expenses)
Non-operating interest income
-65.85%78.50K
-9.79%230.67K
-46.05%206.39K
-60.22%217.79K
-69.23%229.88K
-71.00%255.69K
-57.22%382.56K
-37.50%547.43K
3.34%747.10K
38.65%881.66K
103.61%894.18K
527.86%875.88K
735.12%722.94K
1298.82%635.89K
1614.24%439.17K
--139.50K
--86.57K
--45.46K
--25.62K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-85.23%22.00
334.19%508.00
--988.00
----
--149.00
--117.00
----
--4.65K
----
--0.00
----
----
----
----
Non-operating interest expense
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-93.80%42.00
20.36%467.00
129.58%1.04K
--249.00
--677.00
--388.00
--453.00
----
----
----
----
----
----
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
102.09%483.00
3.97%131.00
83.51%356.00
-9.97%569.00
12.21%239.00
-91.70%126.00
-90.64%194.00
-76.17%632.00
--213.00
-59.65%1.52K
-42.51%2.07K
--2.65K
----
--3.76K
-94.64%3.61K
----
--41.75K
----
--67.27K
----
----
----
----
Gains from sale of securities
--380.68K
--0.00
--2.09M
-100.00%0.00
--0.00
--0.00
--0.00
--21.40M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Special income (expenses)
-126.68%-3.89M
212.59%2.63M
-824.52%-6.89M
-381.35%-7.73M
363.76%14.58M
-735.97%-2.34M
-122.53%-745.00K
238.61%2.75M
--3.14M
--368.00K
--3.31M
---1.98M
----
----
----
----
-100.00%0.00
----
----
----
--75.98K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
--0.00
-100.00%0.00
----
6021.21%1.15M
-100.00%0.00
141.94%2.18M
100.00%0.00
-111.81%-19.50K
805.54%225.92K
-15758.59%-5.21M
-4637.54%-3.26M
--165.12K
-118.41%-32.02K
--33.25K
--71.74K
--173.96K
--0.00
--0.00
- Gains from disposal of fixed assets
100.00%0.00
----
----
----
-28.42%-2.02M
----
----
----
---1.57M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Other non-operating income (expenses)
-16.81%-132.00
-58.00%-632.00
-136401.69%-1.45M
36.32%-121.00
-100.06%-113.00
-58.10%-400.00
-38.82%-1.06K
89.72%-190.00
259.23%194.01K
-100.17%-253.00
27.69%-765.00
52.66%-1.85K
3533.44%54.01K
24379.05%152.96K
-120.42%-1.06K
-144.13%-3.91K
---1.57K
---630.00
---480.00
14.89%-1.60K
100.00%0.00
--0.00
--0.00
---1.88K
-100.12%-40.00
----
----
----
-78.11%33.40K
----
----
----
--152.59K
----
----
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
100.00%0.00
--9.03K
--1.18K
--430.00
---95.00
----
----
----
----
----
----
--0.00
-100.00%0.00
--0.00
--0.00
--0.00
--2.59K
--0.00
--0.00
--0.00
Income before tax
-137.39%-4.39M
124.52%746.86K
-404.78%-7.42M
-135.69%-8.36M
772.47%11.75M
-391.55%-3.05M
-152.67%-1.47M
835.76%23.42M
1165.95%1.35M
18.92%-619.54K
248.36%2.79M
-106.04%-3.18M
91.12%-126.34K
5.81%-764.14K
-91.94%-1.88M
-50.67%-1.55M
-48.20%-1.42M
-7.16%-811.29K
-3.11%-979.75K
-16.00%-1.03M
-27.94%-960.00K
13.51%-757.10K
10.96%-950.19K
22.06%-883.94K
34.12%-750.38K
-29.42%-875.31K
-2.95%-1.07M
6.69%-1.13M
12.08%-1.14M
66.69%-676.35K
42.87%-1.04M
28.02%-1.22M
-12.16%-1.30M
-58.38%-2.03M
-86.17%-1.81M
-63.61%-1.69M
-2.94%-1.16M
28.42%-1.28M
40.42%-974.55K
31.89%-1.03M
60.23%-1.12M
-22.84%-1.79M
59.75%-1.64M
4.40%-1.52M
82.87%-2.82M
-217.82%-1.46M
28.18%-4.06M
66.04%-1.58M
-4934.28%-16.47M
-21.74%-458.77K
-1378.01%-5.66M
-814.05%-4.67M
---327.17K
-38.66%-376.84K
12.43%-382.82K
25.58%-510.52K
---271.78K
---437.15K
---686.02K
Income tax
--0.00
----
----
----
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
----
----
----
----
----
--0.00
----
----
----
----
----
--0.00
----
--0.00
----
--0.00
----
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Income after tax
-137.39%-4.39M
124.52%746.86K
-404.78%-7.42M
-135.69%-8.36M
772.47%11.75M
-391.55%-3.05M
-152.67%-1.47M
835.76%23.42M
1165.95%1.35M
18.92%-619.54K
248.36%2.79M
-106.04%-3.18M
91.12%-126.34K
5.81%-764.14K
-91.94%-1.88M
-50.67%-1.55M
-48.20%-1.42M
-7.16%-811.29K
-3.11%-979.75K
-16.00%-1.03M
-27.94%-960.00K
13.51%-757.10K
10.96%-950.19K
22.06%-883.94K
34.12%-750.38K
-29.42%-875.31K
-2.95%-1.07M
6.69%-1.13M
12.08%-1.14M
66.69%-676.35K
42.87%-1.04M
28.02%-1.22M
-12.16%-1.30M
-58.38%-2.03M
-86.17%-1.81M
-63.61%-1.69M
-2.94%-1.16M
28.42%-1.28M
40.42%-974.55K
31.89%-1.03M
60.23%-1.12M
-22.84%-1.79M
59.75%-1.64M
4.40%-1.52M
82.87%-2.82M
-217.82%-1.46M
28.18%-4.06M
66.04%-1.58M
-4934.28%-16.47M
-21.74%-458.77K
-1378.01%-5.66M
-814.05%-4.67M
---327.17K
-38.66%-376.84K
12.43%-382.82K
25.58%-510.52K
---271.78K
---437.15K
---686.02K
Net income from continuous operations
-137.39%-4.39M
124.52%746.86K
-404.78%-7.42M
-135.69%-8.36M
772.47%11.75M
-391.55%-3.05M
-152.67%-1.47M
835.76%23.42M
1165.95%1.35M
18.92%-619.54K
248.36%2.79M
-106.04%-3.18M
91.12%-126.34K
5.81%-764.14K
-91.94%-1.88M
-50.67%-1.55M
-48.20%-1.42M
-7.16%-811.29K
-3.11%-979.75K
-16.00%-1.03M
-27.94%-960.00K
13.51%-757.10K
10.96%-950.19K
22.06%-883.94K
34.12%-750.38K
-29.42%-875.31K
-2.95%-1.07M
6.69%-1.13M
12.08%-1.14M
66.69%-676.35K
42.87%-1.04M
28.02%-1.22M
-12.16%-1.30M
-58.38%-2.03M
-86.17%-1.81M
-63.61%-1.69M
-2.94%-1.16M
28.42%-1.28M
40.42%-974.55K
31.89%-1.03M
60.23%-1.12M
-22.84%-1.79M
59.75%-1.64M
4.40%-1.52M
82.87%-2.82M
-217.82%-1.46M
28.18%-4.06M
66.04%-1.58M
-4934.28%-16.47M
-21.74%-458.77K
-1378.01%-5.66M
-814.05%-4.67M
---327.17K
-38.66%-376.84K
12.43%-382.82K
25.58%-510.52K
---271.78K
---437.15K
---686.02K
Non-recurring net income
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
----
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net income attributable to controlling interests
-144.93%-4.87M
48.90%-1.56M
-184.45%-8.42M
-155.89%-8.36M
526.94%10.85M
45.81%-3.05M
-31.03%-2.96M
320.77%14.96M
-1910.91%-2.54M
-635.49%-5.62M
-20.08%-2.26M
-338.52%-6.78M
91.12%-126.34K
5.81%-764.14K
-91.94%-1.88M
-50.67%-1.55M
-48.20%-1.42M
-7.16%-811.29K
-3.11%-979.75K
-16.00%-1.03M
-27.94%-960.00K
13.51%-757.10K
10.96%-950.19K
22.06%-883.94K
34.12%-750.38K
-29.42%-875.31K
-2.95%-1.07M
6.69%-1.13M
12.08%-1.14M
66.69%-676.35K
42.87%-1.04M
28.02%-1.22M
-12.16%-1.30M
-58.38%-2.03M
-86.17%-1.81M
-63.61%-1.69M
-2.94%-1.16M
28.42%-1.28M
40.42%-974.55K
31.89%-1.03M
60.23%-1.12M
-22.84%-1.79M
59.75%-1.64M
4.40%-1.52M
82.87%-2.82M
-217.82%-1.46M
28.18%-4.06M
66.04%-1.58M
-4934.28%-16.47M
-21.74%-458.77K
-1378.01%-5.66M
-814.05%-4.67M
---327.17K
-38.66%-376.84K
12.43%-382.82K
25.58%-510.52K
---271.78K
---437.15K
---686.02K
Preferred share dividend
-46.85%479.97K
--2.30M
-32.95%998.63K
-100.00%0.00
-76.77%903.05K
-100.00%0.00
-70.50%1.49M
135.64%8.46M
--3.89M
--5.00M
--5.05M
--3.59M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net income attributable to common shareholders
-144.93%-4.87M
48.90%-1.56M
-184.45%-8.42M
-155.89%-8.36M
526.94%10.85M
45.81%-3.05M
-31.03%-2.96M
320.77%14.96M
-1910.91%-2.54M
-635.49%-5.62M
-20.08%-2.26M
-338.52%-6.78M
91.12%-126.34K
5.81%-764.14K
-91.94%-1.88M
-50.67%-1.55M
-48.20%-1.42M
-7.16%-811.29K
-3.11%-979.75K
-16.00%-1.03M
-27.94%-960.00K
13.51%-757.10K
10.96%-950.19K
22.06%-883.94K
34.12%-750.38K
-29.42%-875.31K
-2.95%-1.07M
6.69%-1.13M
12.08%-1.14M
66.69%-676.35K
42.87%-1.04M
28.02%-1.22M
-12.16%-1.30M
-58.38%-2.03M
-86.17%-1.81M
-63.61%-1.69M
-2.94%-1.16M
28.42%-1.28M
40.42%-974.55K
31.89%-1.03M
60.23%-1.12M
-22.84%-1.79M
59.75%-1.64M
4.40%-1.52M
82.87%-2.82M
-217.82%-1.46M
28.18%-4.06M
66.04%-1.58M
-4934.28%-16.47M
-21.74%-458.77K
-1378.01%-5.66M
-814.05%-4.67M
---327.17K
-38.66%-376.84K
12.43%-382.82K
25.58%-510.52K
---271.78K
---437.15K
---686.02K
Basic earnings per share
-128.90%-0.46
61.60%-0.17
-219.66%-1.24
-164.70%-1.23
620.06%1.58
32.99%-0.44
-50.39%-0.39
453.67%1.90
-4185.21%-0.30
-1523.09%-0.65
-182.01%-0.26
-624.86%-0.54
89.28%-0.01
-7.45%-0.04
-61.85%-0.09
88.49%-0.07
89.12%-0.07
92.20%-0.04
90.82%-0.06
18.94%-0.64
15.43%-0.61
50.00%-0.48
49.38%-0.61
43.62%-0.80
51.52%-0.72
-6.67%-0.96
15.62%-1.22
18.97%-1.41
23.85%-1.48
71.15%-0.90
48.39%-1.44
36.26%-1.74
0.76%-1.95
-39.60%-3.12
-61.74%-2.79
-38.93%-2.73
10.27%-1.96
37.13%-2.23
47.49%-1.73
36.10%-1.96
63.32%-2.19
-13.40%-3.56
62.11%-3.29
9.29%-3.08
83.85%-5.97
-175.00%-3.13
44.69%-8.67
74.72%-3.39
-3421.43%-36.98
10.59%-1.14
-1074.16%-15.68
-632.79%-13.41
---1.05
-16.44%-1.27
23.93%-1.33
34.76%-1.83
---1.09
---1.75
---2.81
Diluted earnings per share
-128.90%-0.46
61.60%-0.17
-219.66%-1.24
-164.70%-1.23
620.06%1.58
32.99%-0.44
-50.39%-0.39
453.67%1.90
-4185.21%-0.30
-1523.09%-0.65
-182.01%-0.26
-624.86%-0.54
89.28%-0.01
-7.45%-0.04
-61.85%-0.09
88.49%-0.07
89.12%-0.07
92.20%-0.04
90.82%-0.06
18.94%-0.64
15.43%-0.61
50.00%-0.48
49.38%-0.61
43.62%-0.80
51.52%-0.72
-6.67%-0.96
15.62%-1.22
18.97%-1.41
23.85%-1.48
71.15%-0.90
48.39%-1.44
36.26%-1.74
0.76%-1.95
-39.60%-3.12
-61.74%-2.79
-38.93%-2.73
10.27%-1.96
37.13%-2.23
47.49%-1.73
36.10%-1.96
63.32%-2.19
-13.40%-3.56
62.11%-3.29
9.29%-3.08
83.85%-5.97
-175.00%-3.13
44.69%-8.67
74.72%-3.39
-3421.43%-36.98
10.59%-1.14
-1074.16%-15.68
-632.79%-13.41
---1.05
-16.44%-1.27
23.93%-1.33
34.76%-1.83
---1.09
---1.75
---2.81
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

How do I read PharmaCyte Biotech Inc's income statement on TradingKey?

Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.

What is the difference between quarterly and annual income statements?

A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.

What does YOY mean on the income statement page?

YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.

Which income statement metrics matter most when analyzing PMCB stock?

Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.

What was PharmaCyte Biotech Inc's net income for the year?

PharmaCyte Biotech Inc posted -23.21M in net income for fiscal year 2025.

How much net income did PharmaCyte Biotech Inc post in the last quarter?

PharmaCyte Biotech Inc reported -4.87M in net income for the latest quarter。

What was PharmaCyte Biotech Inc's annual operating profit?

PharmaCyte Biotech Inc's operating income was -4.38M for fiscal year 2025.

How is EPS related to the income statement?

EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.